<SEC-DOCUMENT>0001373604-25-000071.txt : 20250506
<SEC-HEADER>0001373604-25-000071.hdr.sgml : 20250506
<ACCEPTANCE-DATETIME>20250506091554
ACCESSION NUMBER:		0001373604-25-000071
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250506
DATE AS OF CHANGE:		20250506

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adverum Biotechnologies, Inc.
		CENTRAL INDEX KEY:			0001501756
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				205258327
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88266
		FILM NUMBER:		25915610

	BUSINESS ADDRESS:	
		STREET 1:		100 CARDINAL WAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		(650) 649-1004

	MAIL ADDRESS:	
		STREET 1:		100 CARDINAL WAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avalanche Biotechnologies, Inc.
		DATE OF NAME CHANGE:	20100921

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BML Investment Partners, L.P.
		CENTRAL INDEX KEY:			0001373604
		ORGANIZATION NAME:           	
		EIN:				383708345
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		65 E CEDAR - SUITE 2
		CITY:			ZIONSVILLE
		STATE:			IN
		ZIP:			46077
		BUSINESS PHONE:		317-344-2447

	MAIL ADDRESS:	
		STREET 1:		65 E CEDAR - SUITE 2
		CITY:			ZIONSVILLE
		STATE:			IN
		ZIP:			46077
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0001567619-22-009896</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001373604</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>5</amendmentNo>
<securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001501756</issuerCik>
<issuerName>Adverum Biotechnologies, Inc.</issuerName>
<issuerCusip>00773U108</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>100 Cardinal Way</com:street1>
<com:city>Redwood cITY</com:city>
<com:stateOrCountry>CA</com:stateOrCountry>
<com:zipCode>94063</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>BML Investment Partners, L.P.</reportingPersonName>
<memberGroup>b</memberGroup>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>2742317</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>2742317</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2742317</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>13.1</classPercent>
<typeOfReportingPerson>PN</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Leonard Braden Michael</reportingPersonName>
<memberGroup>b</memberGroup>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>140000</soleVotingPower>
<sharedVotingPower>2742317</sharedVotingPower>
<soleDispositivePower>140000</soleDispositivePower>
<sharedDispositivePower>2742317</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2882317</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>13.8</classPercent>
<typeOfReportingPerson>IN</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>Adverum Biotechnologies, Inc.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>100 Cardinal Way, Redwood cITY, California, 94063</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>BML Investment Partners, L.P.</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>65 E Cedar - Suite 2&#13;
Zionsville, IN 46077</principalBusinessOfficeOrResidenceAddress>
<citizenship>Delaware</citizenship>
</item2>
<item3>
<notApplicableFlag>Y</notApplicableFlag>
</item3>
<item4>
<amountBeneficiallyOwned>2882317</amountBeneficiallyOwned>
<classPercent>13.8</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>140000</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>2742317</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>140000</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>2742317</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>Y</notApplicableFlag>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>Y</notApplicableFlag>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>BML Investment Partners, L.P.</reportingPersonName>
<signatureDetails>
<signature>Braden M Leonard</signature>
<title>BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member</title>
<date>05/06/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>Leonard Braden Michael</reportingPersonName>
<signatureDetails>
<signature>Braden M Leonard</signature>
<title>Leonard Braden Michael</title>
<date>05/06/2025</date>
</signatureDetails>
</signatureInformation>
<signatureComments>BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.</signatureComments>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
